Computer-designed proteins may protect against coronavirus
On Sept. 29, 2020, the National Institutes of Health (NIH) announced that researchers had designed ”miniproteins’ that bound…
On Sept. 29, 2020, the National Institutes of Health (NIH) announced that researchers had designed ”miniproteins’ that bound…
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the U.S. Food and Drug…
On Sept. 29, 2020, Moderna announced the publication of the second interim analysis of the open-label Phase 1…
On Sept. 29, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that a phase 1…
On Sept. 29, 2020, a phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection was…
On Sept. 29, 2020, In a new Letter, published in PNAS, researchers at La Jolla Institute for Immunology…
On Sept. 29, 2020, Regeneron announced the first data from a descriptive analysis of a seamless Phase 1/2/3…
On Sept. 29, 2020, AXIM Biotechnologies announced that it has filed a provisional patent for a first-in-class face…
On Sept. 29, 2020, Windtree Therapeutics announced that U.S. Food and Drug Administration (FDA) has accepted its Investigational…
On Sept. 28, 2020, a genetic study identified neuronal abnormalities in the electrical activity of cortical cells derived…
On Sept. 28 2020, ViroVax announced that it had licensed its adjuvant, Alhydroxiquim-II, to Bharat Biotech International, an…
On Sept. 28, 2020, the U.S. Departments of Defense and Health and Human Services signed a $20 million…
On Sept. 28, 2020, Hologic announced that its Panther Fusion SARS-CoV-2 assay had received Emergency Use Authorization (EUA)…
On Sept. 28, 2020, as COVID-19 infections began to rise again, a novel testing strategy was proposed by…
On Sept. 28, 2020, in an article published in Nature Genetics, researchers confirmed that about 14% of all…
On Sept. 28, 2020, Tonix Pharmaceuticals announced that it had completed the purchase a 40,000 square foot facility…
On Sept. 28, 2020, Immunic announced the results of a pre-planned interim safety analysis and a recruitment update…
On Sept. 28, 2020, INOVIO announced that the U.S. Food and Drug Administration (FDA) has notified the company…
On Sept. 28, 2020, the World Health Organization (WHO) announced agreements to make available, for low and middle-income…
On Sept. 25, 2020, the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Sept. 25, 2020, scientists from the University of Oxford’s Nuffield Department of Medicine published their evaluation of…
On Sept. 25, 2020, Todos Medical announced that it had entered into an implementation and equipment financing partnership…
On Sept. 24, 2020, Lumen Bioscience and the US Army Medical Research and Development Command, announced an agreement…
On Sept. 24, 2020, an international research team led by the Max Planck Institute for Evolutionary Anthropology in…
On Sept. 24, 2020, findings reported by scientists at the National Institutes of Health (NIH) their collaborators help…
On Sept. 24, 2020, a team of scientists announced they had created the first atlas of human heart…
On Sept. 24, 2020, Novavax announced that it had initiated its first Phase 3 study to evaluate the…
On Sept. 24, 2020, Yale University announced it had designated three independent laboratories to perform the university-developed SalivaDirect…
On Sept. 24, 2020, the U.S. Department of Health and Human Services and the U.S. Food and Drug…
On Sept. 23, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for…